Over the past weeks, we've introduced four additional innovators at the forefront of cancer: ONCO-LIQ - Cancer detection through routine blood testing TELEXOS - Improved cancer diagnostics through detection of circulating tumor cells in blood BETAGLUE -...
Cancer Sucks. We Know.
The Lowdown on Cancer focuses on the impact of cancer on lives and on the things that give us hope. From the pain of learning you have cancer to innovative new treatments offered by the best and brightest, we’ll give you the Lowdown.
Yes, cancer sucks. But you are not alone. And we are not without hope!
CANCER FUND. More than Hope.
Save Second Base, The Innovators: Onco-liq
"We know that 50% of humans will have cancer at some time in their life." Well if that wasn't enough of a gut punch, wait for this statistic: Of those people with cancer, 50% will be diagnosed with advanced tumors. Which means treatment options may be...
Save Second Base, The Innovators: Telexos GmbH
Meet Telexos GmbH. Telexos develops products for the clinical cancer research market and for the personalized cancer diagnostics market. Their focus is on the detection and analysis of rare cells in the blood, in particular circulating tumor cells (CTCs)...
Save Second Base, The Innovators: BetaGlue Technologies
We scoured the globe to bring you this latest innovator! Meet BetaGlue Technologies, a global team of medical industry professionals developing a new technology in the loco-regional therapy of solid tumors. And while it may sound like the stuff of sci-fi...
Save Second Base, The Innovators: InheRET
1 in 5 Americans are at increased risk for hereditary or genetic risk of developing cancer. But most don't even realize it. Sure, we've all filled out those family history forms at the doctor's office. But how well informed were you about your family...
Save Second Base, The Innovators: FixNip
In 2021, an estimated 323,840 new cases of breast cancer are expected to be diagnosed in men and women in the U.S. alone. Approximately 43% of those cases will choose surgical breast reconstruction. Although nipple-sparing surgeries (leaving the...
Save Second Base, The Innovators: Cancer U
Our latest innovator bucks the trend, as a "for-profit, social impact, health tech startup." The cancer journey is overwhelming for patients and caregivers. And while many people struggle to advocate for themselves and their loved ones after a cancer...
Save Second Base, The Innovators: Concarlo Holdings, LLC
We've shared some gut-wrenching stories as part of "Save Second Base," our series on breast cancer. But now we share some glimmers of hope. CANCER FUND is more than hope. Through investing in innovation, we bring diagnostics, treatments, and solutions to...
Crossing the “Valley of Death”: An Update on Reglagene
Join us for this special update from Reglagene, the first company in CANCER FUND's portfolio of investments. Reglagene is working to develop targeted cancer therapies, delivered via oral medication, that control cancer cells' ability to become...
The Innovator Pipeline: How CANCER FUND Supports Innovation
Research is only the first step when it comes to cancer innovations. But there are many more stops along the journey from lab to patient. And the catalyst behind it all? Funding, of course! Meet Jon Mengel from CANCER FUND, as he discusses the nearly 150...
Diagnostics & Monitoring: The Innovators Recap
As we wrap up our latest series, “Measure Twice, Cut Once: Diagnostics and Monitoring,” let’s take a look back at the four innovators who joined us to share about their innovative technologies.
The Innovators: Cormometer
Stress, cortisol, cancer, and YOU. Meet Jeff Rea of Cormometer, an exciting innovation that puts the patient in the driver seat when it comes to monitoring hormonal stress that can impact cancer treatment and overall wellness....
The Innovators: BCAL Diagnostics
The most common type of cancer is breast cancer, with 279,100 new cases in the United States in 2020. But there is still so much work to be done to properly diagnosis breast cancer early to save lives and provide less invasive treatments. Jayne Shaw,...
The Innovators: Quantitative Radiology Solutions
Meet Innovator #2 of our "Diagnostics & Monitoring" series, Joe Camaratta, CEO of Quantitative Radiology Solutions. Joe has pivoted his 30 year background in medical imaging and healthcare IT to focus on bringing ideas out of academia and to market....
The Innovators: SWAN Cytologics
Meet biomedical engineer Aaron Weinroth as he discusses SWAN Cytologics and their "elegant solution" to the "inadequacy, inefficiency, and trauma" of traditional needle biopsies. https://youtu.be/gOkNGBP9dak
Evaluating Early Stage Cancer Innovation Companies
Meet Greg O'Ryan Johnson, Venture Scout Associate. In his role at the CANCER FUND, Greg contributes by evaluating early stage companies through due diligence and analytical processes. Greg’s mission while at the CANCER FUND is to help entrepreneurs bring...
The Innovators’ Reality: The Need for Funding
The innovators we speak with all have one major thing in common - yes, they're part of the fight against cancer, but more pressing is that the only road to the finish line requires FUNDING. That's why CANCER FUND was formed. We invest in cancer...
The Bitch Is Back: Series Review
Thank you for joining us on the journey to explore cancer recurrence in our series “The Bitch Is Back.” Cancer recurrence rates vary widely depending on the type of cancer and other factors, but occurs in roughly 70% of cancer patients, with higher rates...
Cancer Recurrence: The Innovators Recap
Tune in for a quick recap of our four innovators as they explain the products their teams are working on to battle cancer recurrence. https://youtu.be/Jl4UiXnrQ_M
The Innovators: Reglagene
Meet Richard Austin, CEO/President of Reglagene, a company out to discover and develop low-cost and noninvasive therapeutic solutions that regain control of genes exploited by cancer to keep patients responsive to treatment....
The Innovators: Celestra
Meet David Lu, a research scientist at the Yale Cancer Biology Institute and co-founder of Celestra Life Science. Learn about David and his team at Celestra, where they are combining innovations in synthetic lethality and nanotechnology to develop a new...
The Innovators: Inflection BioSciences
Meet Darren Cunningham, CEO of Inflection BioSciences, an early-stage drug development company focused on discovering and developing innovative small molecule therapeutics to treat cancer and cancer recurrences. https://youtu.be/26GsLg7uj9o
The Innovators: OncoSynergy
In our latest series, “The Bitch Is Back,” we have heard from community members about “The Problem,” their struggles with cancer recurrence. We’ve heard from the expert, Dr. Rachna Shroff, to better understand how cancer recurrence happens and how...
Drug Hunters!
The Lowdown wants to change researchers name to . . . https://youtu.be/bRMqsrSOhAY
Cancer is a Moving Target
Cancer is a sneaky bastard! Listen to Dr. Richard Austin give some perspective on curing cancer https://youtu.be/Z1YmyLlRvbQ
What Will Richard Tell Us Today About Being a Scientist?
We can't understand everything. Stop them and ask questions. It's ok. https://youtu.be/AEzBUjf2Wo4
Cancer Changes
Everyone is different, don't use others' treatment and side effects as the norm. You are your own person. You will have a different path then the next person or the people before you. https://youtu.be/cr_0bln9jXE
Healthcare Automation – Will it Affect Your Future Care?
Ann is joined by James Bates, CEO of the healthcare automation innovation known as AdviNow Medical. Listen in as he shares the exciting changes that artificial intelligence brings to the future of healthcare. https://youtu.be/M-7hCKTfpDM
Why do most Cancer Innovations Fail?
What is the “Valley of Death” and how do companies get over it? https://youtu.be/sg3LNCSlEAo